Introduction
============

Premature ovarian failure (POF) refers to the presence of ovarian atrophy-associated permanent amenorrhea in women under 40 ([@b1-mmr-14-03-2415],[@b2-mmr-14-03-2415]). The levels of follicle stimulating hormone (FSH) are significantly increased in peripheral blood while the levels of estradiol (E2) are significantly decreased ([@b1-mmr-14-03-2415],[@b3-mmr-14-03-2415]). Histopathological examination of ovarian tissues has revealed significant atrophy and fibrosis, marked follicular atresia and the absence of normal follicular stages (including primordial follicle, antral follicle, cumulus oophorus and mature egg) ([@b3-mmr-14-03-2415]--[@b5-mmr-14-03-2415]). The underlying mechanisms of POF development are diverse and complex. Currently, the pathogenesis of POF remains to be elucidated, and no effective treatment measures exist.

Telocytes are a group of highly specialized cells in the connective tissues of organs ([@b6-mmr-14-03-2415]--[@b8-mmr-14-03-2415]). Telocytes have a small cell volume and long cytoplasmic prolongations (typically 10--100 *µ*m in length), referred to as telopodes ([@b9-mmr-14-03-2415]--[@b11-mmr-14-03-2415]). The dichotomous branching structure of telopodes may be observed by electron microscopy ([@b12-mmr-14-03-2415]--[@b14-mmr-14-03-2415]), which reveals that telopodes consist of thick branching segments (podoms) and thin branching segments (podomers) ([@b15-mmr-14-03-2415],[@b16-mmr-14-03-2415]). It has been demonstrated that telocytes are present in the connective tissues of numerous organs in mammals, including myocardial tissue ([@b6-mmr-14-03-2415],[@b9-mmr-14-03-2415],[@b11-mmr-14-03-2415],[@b12-mmr-14-03-2415]), uterus and fallopian tubes ([@b10-mmr-14-03-2415],[@b11-mmr-14-03-2415],[@b16-mmr-14-03-2415]), placental tissues ([@b11-mmr-14-03-2415]), ureter ([@b10-mmr-14-03-2415],[@b11-mmr-14-03-2415],[@b17-mmr-14-03-2415]), skeletal muscle ([@b11-mmr-14-03-2415],[@b17-mmr-14-03-2415],[@b18-mmr-14-03-2415]), lung ([@b9-mmr-14-03-2415],[@b11-mmr-14-03-2415]), mammary gland ([@b11-mmr-14-03-2415]), liver ([@b11-mmr-14-03-2415],[@b19-mmr-14-03-2415]--[@b21-mmr-14-03-2415]) and pancreas ([@b11-mmr-14-03-2415],[@b14-mmr-14-03-2415]). Although no telocyte-specific marker has been identified to date, previous studies have reported increased expression of cluster of differentiation (CD)34, CD117 (c-kit), platelet-derived growth factor receptor (PDGFR)α, PDGFRβ and vimentin ([@b6-mmr-14-03-2415]--[@b22-mmr-14-03-2415]). Previous studies have demonstrated that telocytes have the following biological functions: i) Telocytes may guide the migration of cardiac stromal cells from the endothelium to mesothelium and contribute to vascular regeneration of myocardial tissues following myocardial infarction ([@b6-mmr-14-03-2415],[@b8-mmr-14-03-2415],[@b11-mmr-14-03-2415],[@b12-mmr-14-03-2415]); ii) telocytes form a complex network structure in the lung via their telopodes that support the bronchial lumens of lobules, thus preventing obstruction of lobules and small blood vessels with weak vascular walls during the respiratory process ([@b9-mmr-14-03-2415],[@b12-mmr-14-03-2415]); iii) telocytes affect antigen presentation, immune activation and immune tolerance, via the release of microvesicles during synapses with immune cells ([@b8-mmr-14-03-2415]); and iv) as \'stem cell helper cells\', telocytes facilitate repair and regeneration at injured sites through cross-linking to form stem cell niches ([@b11-mmr-14-03-2415],[@b12-mmr-14-03-2415],[@b16-mmr-14-03-2415],[@b20-mmr-14-03-2415]). However, whether telocytes are present in the mammalian ovary and contribute to the regulation of ovarian function remains to be determined ([@b11-mmr-14-03-2415]). In the present study, electron microscopy combined with immunofluorescence analysis and flow cytometry was performed to investigate the hypothesis that telocytes are present in ovarian tissues in mice. In addition, telocytes were investigated as a potential novel marker of POF in mice induced by cyclophosphamide.

Materials and methods
=====================

Establishment of a POF mouse model
----------------------------------

POF was induced in mice according to a previously described method ([@b3-mmr-14-03-2415]--[@b5-mmr-14-03-2415]). Briefly, 8-week-old female C57BL/6 mice (n=40) were purchased from the Experimental Animal Center of Shanghai University of Traditional Chinese Medicine (Shanghai, China). Mice were housed in a temperature-controlled environment under standard light-dark cycles with *ad libitum* access to food and water as previously described ([@b3-mmr-14-03-2415]). Mice were randomly divided into two groups (20 mice/group). Mice in the POF group were injected intraperitoneally with 70 mg/kg cyclophosphamide (Sigma-Aldrich, St. Louis, MO, USA), followed by intraperitoneal injections of 30 mg/kg cyclophosphamide every three days for three weeks, to establish the POF mouse model. Mice in the control group were injected intraperitoneally with an equal volume of normal saline every three days for three weeks. All mice were sacrificed by cervical dislocation at three weeks and the ovaries were harvested for subsequent analysis. The study was approved by the Ethics Committee of Shanghai Geriatric Institute of Chinese Medicine (Shanghai, China; ref. SHAGESYDW2015026). All experiments conformed to standards set by the Laboratory Animal Regulation of the State Scientific and Technological Commission ([www.slarc.org.cn](http://www.slarc.org.cn)).

Hematoxylin and eosin (H&E) staining
------------------------------------

H&E staining was performed according to a previously described method ([@b3-mmr-14-03-2415]). Briefly, fresh tissues were immersed in 4% paraformaldehyde (Sigma-Aldrich) for 30 min at room temperature to allow fixation. Tissues were dehydrated using an ethanol gradient, embedded in paraffin, sectioned (thickness, 6 *µ*m) and deparaffinized in xylene (Sigma-Aldrich). Tissue sections were stained with H&E (Sigma-Aldrich), cleared in xylene and mounted on slides using neutral balsam (Sigma-Aldrich). The number of atretic follicles was counted per microscope field, in three non-overlapping fields of ovary sections from each mouse.

Immunofluorescence staining
---------------------------

Immunofluorescence staining was performed as previously described ([@b4-mmr-14-03-2415]). Briefly, fresh tissues were fixed and sectioned as for H&E staining. Tissue sections were incubated with immunofluorescence blocking solution (Beyotime Institute of Biotechnology, Haimen, China) for 30 min at 37°C. Subsequently, sections were washed three times in immunofluorescence wash solution (Beyotime Institute of Biotechnology) for 5 min at room temperature. Sections were incubated with primary antibodies ([Table I](#tI-mmr-14-03-2415){ref-type="table"}) for 45 min at 37°C. The washing step was repeated, and sections were incubated with secondary antibodies ([Table II](#tII-mmr-14-03-2415){ref-type="table"}) for 45 min at 37°C. Following a final repeat of the washing step, sections were mounted using Kisser\'s Mounting Medium (Beyotime Institute of Biotechnology).

Immunohistochemical staining
----------------------------

Immunohistochemical staining was performed as previously described ([@b4-mmr-14-03-2415]). Briefly, ovarian tissue samples were washed three times with phosphate-buffered saline (PBS; Sigma-Aldrich), fixed with 4% paraformaldehyde (Sigma-Aldrich) for 30 min, dehydrated through a graded series of ethanol, cleared in xylene and embedded in paraffin. Subsequently, serial 6-*µ*m thick sections were cut, rinsed with 3% phosphate buffer (Sigma-Aldrich), and subjected to heat retrieval in a microwave. The sections were then incubated with primary antibodies ([Table I](#tI-mmr-14-03-2415){ref-type="table"}) for 45 min at 37°C. Subsequently, sections were washed three times in immunohistochemistry wash solution (Beyotime Institute of Biotechnology) for 5 min at room temperature. Sections were incubated with secondary antibodies ([Table II](#tII-mmr-14-03-2415){ref-type="table"}) for 45 min at 37°C. Following a repeat of the washing step, ABC chromogenic reagent (Sigma-Aldrich) was added to visualize bound antibody. PBS (pH 7.4) was used as a negative control for primary antibody. Sections were mounted using neutral balsam (Beyotime Institute of Biotechnology). Five randomly selected fields of view (magnification, ×200; Olympus BX43; Olympus Corporation, Tokyo, Japan) were assessed for each tissue section and analyzed using Integrated Performance Primitives software version 4.0 (Intel Corporation, Santa Clara, CA, USA).

Enzyme-linked immunosorbent assay (ELISA)
-----------------------------------------

Mouse blood was obtained by retro-orbital blood collection at sacrifice (\~100 *µ*l blood from each mouse) and centrifuged at 453 × g at 4°C for 10 min. The supernatants were collected and these serum samples were used for ELISA. ELISAs were performed according to the manufacturer\'s instructions for the mouse E2 and FSH ELISA kits (Westang Bio-Tech Co., Ltd., Shanghai, China). Briefly, 100 *µ*l serum, along with mouse E2 standards (at concentrations of 8,000, 4,000, 2,000, 1,000, 500, 250 and 125 pg/ml) and mouse FSH standards (at concentrations of 10, 5, 2.5, 1.25, 0.625, 0.312 and 0.156 ng/ml), was added to pre-coated 96-well detection plates and incubated for 60 min at 37°C. The solution was discarded and the plates were washed three times with wash solution. Horseradish peroxidase-conjugated detection antibodies were added and incubated for 60 min at 37°C. Subsequently, stop solution was added and the optical density of each well in the 96-well plate was measured at a wavelength of 450 nm.

Flow cytometry
--------------

Cells were isolated and flow cytometry was performed according to a previously described method ([@b5-mmr-14-03-2415],[@b10-mmr-14-03-2415]). Briefly, the murine ovaries were minced into small pieces (\~1 mm^3^) and washed three times with PBS at 4°C. The samples were digested using 10 mg/ml collagenase type I (Sigma-Aldrich) and 0.1% hyaluronidase (Sigma-Aldrich) in PBS for 5 min on an orbital shaker at 37°C, and filtered through 40-*µ*m diameter cell strainers. These granulosa cells from ovaries were fixed in 4% paraformaldehyde for 30 min at room temperature. Following centrifugation at 453 × g for 5 min at 37°C, the supernatant was discarded and the cell precipitate was resuspended in blocking solution (Beyotime Institute of Biotechnology) for 30 min at 37°C. Cells were centrifuged, the blocking solution was discarded, and primary antibodies ([Table I](#tI-mmr-14-03-2415){ref-type="table"}) were added and incubated for 45 min at 37°C. Following centrifugation, the antibodies were discarded and wash solution (Beyotime Institute of Biotechnology) was added to the cells for 5 min at room temperature. Cells were then centrifuged, and secondary antibodies ([Table II](#tII-mmr-14-03-2415){ref-type="table"}) were added and incubated for 30 min at 37°C. Following centrifugation, the antibodies were discarded and wash solution (Beyotime Institute of Biotechnology) was added to the cells for 5 min at room temperature. Positive cells were detected by flow cytometry (Quanta SC; Beckman Coulter, Inc., Brea, CA, USA).

Preparation of samples and observation using electron microscopy
----------------------------------------------------------------

Samples were fixed and embedded according to a previous study ([@b23-mmr-14-03-2415]) and the protocol provided by KingMed Center for Clinical Laboratory Co., Ltd. (Guangzhou, China). Tissue samples were fixed in 1% glutaraldehyde (Sigma-Aldrich) for 4 h followed by 1% osmium tetroxide (Sigma-Aldrich) for 1 h. Samples were then dehydrated in acetone and embedded in Eponate 12 resin (Ted Pella, Inc., Redding, CA, USA). Samples were cut into ultrathin sections (thickness, 70 nm), placed on copper grids and stained using 1% uranyl acetate and 1% lead citrate (Sigma-Aldrich). The sections were observed and images captured using a JEM-1230 transmission electron microscope (JEOL, Ltd., Tokyo, Japan).

Statistical analysis
--------------------

Statistical analyses were performed in GraphPad Prism software version 5.00 (GraphPad Software, Inc., La Jolla, CA, USA). The data are presented as the mean ± standard error where applicable; differences were evaluated using Student\'s *t*-test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

Cyclophosphamide induces ovarian damage and abnormal hormone secretion in mice
------------------------------------------------------------------------------

Histological analysis with H&E staining revealed that the number of atretic follicles in the ovaries of cyclophosphamide-treated mice was significantly increased compared with the control group (P=0.018; [Fig. 1A](#f1-mmr-14-03-2415){ref-type="fig"}). In addition, the texture of ovarian tissues was dense in control mice. Various stages of follicles were observed in ovaries, including primordial follicles ([Fig. 1B](#f1-mmr-14-03-2415){ref-type="fig"}; pink arrows), antral follicles ([Fig. 1B](#f1-mmr-14-03-2415){ref-type="fig"}; red arrows), cumulus oophorus ([Fig. 1B](#f1-mmr-14-03-2415){ref-type="fig"}; blue arrows) and mature eggs ([Fig. 1B](#f1-mmr-14-03-2415){ref-type="fig"}; black arrows). Following treatment with cyclophosphamide for three weeks, ovarian tissues demonstrated significant atrophy, the ovarian stroma had empty space, and apoptosis and necrosis in ovarian granulosa cells was significant ([Fig. 1B](#f1-mmr-14-03-2415){ref-type="fig"}; yellow arrows). In addition, it was difficult to identify the various stages of follicles and mature eggs, and atretic follicles and luteal tissue atrophy were abundant ([Fig. 1B](#f1-mmr-14-03-2415){ref-type="fig"}). Immunohistochemistry results ([Fig. 1C](#f1-mmr-14-03-2415){ref-type="fig"}) indicated that the expression of the ovarian granulosa cell markers anti-Müllerian hormone (AMH) and inhibinα/β in the ovaries of POF mice was reduced compared with control mice; however, no difference was observed in FSH receptor (FSHR) staining between the two groups. The weight of ovarian tissues from cyclophosphamide-treated mice was significantly reduced compared with that of control mice (P=0.022; [Fig. 2A](#f2-mmr-14-03-2415){ref-type="fig"}). ELISA results demonstrated that the peripheral blood E2 level in mice treated with cyclophosphamide was significantly reduced compared with the control group (P=0.015; [Fig. 2B](#f2-mmr-14-03-2415){ref-type="fig"}), and the FSH level was significantly increased compared with the control group (P=0.027; [Fig. 2C](#f2-mmr-14-03-2415){ref-type="fig"}). Histological and hormone level detection results therefore suggested that cyclophosphamide induced ovarian granulosa cell injury and apoptosis as well as the development of POF.

Telocytes are present in normal ovarian tissues
-----------------------------------------------

Transmission electron microscopy was performed to confirm that telocytes were present in ovarian tissues. A unique type of cell body was observed in the ovarian stroma in control mice. Although the cell volume was small, it had very long telopodes, which had a typical dichotomous branching structure and alternating thick and thin segments ([Fig. 3](#f3-mmr-14-03-2415){ref-type="fig"}). However, cells with these morphological features were not observed in ovarian tissues from POF mice. Following a review of the literature, it was hypothesized that these cells were telocytes.

Cyclophosphamide induces a reduction in telocyte number and marker expression levels
------------------------------------------------------------------------------------

Flow cytometry detection of telocyte markers revealed that the number of CD34/PDGFRα, CD34/PDGFRβ and CD34/vimentin double-positive cells in the ovaries of POF mice was significantly reduced compared with control mice (P=0.031; [Fig. 4](#f4-mmr-14-03-2415){ref-type="fig"}), whereas the number of CD34/c-kit double-positive cells was not significantly different between the two groups (P=0.061; [Fig. 4](#f4-mmr-14-03-2415){ref-type="fig"}). In addition, immunofluorescence staining results indicated that the number of CD34/PDGFRα, CD34/PDGFRβ and CD34/vimentin double-positive cells in the ovarian tissues of POF mice was decreased compared with control mice ([Fig. 5](#f5-mmr-14-03-2415){ref-type="fig"}). These results suggested that the number of telocytes significantly decreased in ovarian tissues of mice following cyclophosphamide treatment.

Discussion
==========

POF is associated with complex risk factors and high morbidity ([@b2-mmr-14-03-2415]). Typically, studies have focused on the effects of risk factors, including genetic variations, immunity and inflammation, environmental hormones and contamination, personal stress, and endocrine disorders ([@b1-mmr-14-03-2415],[@b2-mmr-14-03-2415]). During the development of POF, lesions are most prominent in egg and ovarian granulosa cells ([@b4-mmr-14-03-2415],[@b5-mmr-14-03-2415],[@b24-mmr-14-03-2415]). Ovarian granulosa cells, similar to Sertoli cells of the male reproduction system, support female reproductive cells i.e. mature egg cells ([@b3-mmr-14-03-2415]), surrounding these cells during follicle development to form a unique microenvironment. Ovarian granulosa cells secrete hormones and cytokines for egg maturation, including estrogen, FSH, anti-Müllerian antibody, inhibinα/β and growth hormone, to support the development, maturation and ovulation of follicles ([@b3-mmr-14-03-2415]). Ovarian granulosa cell apoptosis reduces the follicular reserve capacity of the ovary, thus causing the development of POF ([@b1-mmr-14-03-2415],[@b5-mmr-14-03-2415]). In the ovaries of POF patients, ovarian granulosa cells typically exhibit apoptosis and edema ([@b4-mmr-14-03-2415]). The primary function of the ovary is to provide a location for egg maturation. Therefore, in the ovaries of POF patients, the number of atretic follicles is significantly increased and the number of healthy follicles is significantly decreased; in addition, the number of follicles at various stages is significantly decreased ([@b2-mmr-14-03-2415]). As well as egg and ovarian granulosa cells, other types of cell, including ovarian stromal cells, ovarian epithelial cells and ovarian microvascular endothelial cells are affected by POF; however, there have been limited studies on their functions.

A literature search revealed reports of a unique cell type present in the respiratory, cardiovascular and digestive systems; these cells were telocytes ([@b6-mmr-14-03-2415]--[@b22-mmr-14-03-2415]). Telocytes are predominantly localized in the connective tissues of organs. Telocyte features include a small cell volume, very long cytoplasmic prolongations (telopodes) and a typical dichotomous branching structure of these telopodes ([@b6-mmr-14-03-2415]--[@b22-mmr-14-03-2415]). Telopodes comprise a complex network structure, which supports the lumen of lobular bronchioles and blood vessels to prevent obstruction. In addition, as \'stem cell helper cells\', telocytes form stem cell niches through cross-linking to facilitate the repair and regeneration of injured sites ([@b6-mmr-14-03-2415]--[@b22-mmr-14-03-2415]). However, in mammals, not every organ contains telocytes and it has not been reported whether they are present in ovaries.

As telocytes function to maintain the microenvironment, it was hypothesized that ovaries may contain telocytes. Therefore, transmission electron microscopy was performed to analyze the ultra-microstructure of ovarian tissues from control and POF mice. Very long cells were observed in the stroma of healthy mouse ovaries. The somatic synapses of these cells revealed a triangular shape and very long and thin prolongations with a typical dichotomous branching structure, suggesting that these cells may be ovarian tissue telocytes. However, cells with the above morphological features were not observed in the ovaries of POF mice. Subsequently, the expression levels of the telocyte-specific markers CD34, CD117, PDGFRα/β and vimentin were evaluated in ovarian tissues. The results of flow cytometry and immunofluorescence suggested that the number of CD34/PDGFRα, CD34/PDGFRβ and CD34/vimentin double-positive cells in ovarian cells of wild-type mice was significantly increased compared with POF mice. In addition, immunohistochemical staining and flow cytometry experiments suggested that various telocyte markers were expressed in the ovarian tissues of control mice. However, when mice were treated with cyclophosphamide, the expression of telocytes and their markers decreased. Based on the results of the present study, telocytes in ovarian tissues may have an important function in maintaining the ovarian microenvironment. The ovarian tissue injury induced by cyclophosphamide was not confined to ovarian granulosa cells and eggs, as ovarian telocytes were also affected.

In conclusion, mouse ovarian tissues appear to contain telocytes, which highly express CD34, PDGFRα/β and vimentin. The numbers of these cells were significantly reduced following cyclophosphamide treatment. Therefore, telocytes may serve as a potential novel marker of POF induced by cyclophosphamide. Future studies are required to investigate the mechanism underlying the effect of POF on telocytes.
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![Histological analysis of ovaries. (A) The number of atretic follicles in the ovarian tissues of POF mice was significantly increased compared with control mice. ^\*^P\<0.05 vs. WT; n=10. (B) H&E staining of ovarian tissues. Granulosa cells in the ovarian tissues of POF mice demonstrated clear edema and apoptosis, and increased atretic follicles. Ovarian granulosa cell injury is indicated by yellow arrows, primordial follicles by pink arrows, antral follicles by red arrows, mature oocytes by black arrows and cumulus oophorus by blue arrows. (C) Immunohistochemical staining revealed that in ovarian tissues of POF mice, the expression of the ovarian granulosa cell markers AMH, inhibinα and inhibinβ was reduced compared with those of control mice. No difference was observed in the expression of FSHR between the two groups. Black arrows indicate atretic follicles, pink arrows indicate primordial follicles, yellow arrows indicate cumulus oophorus and blue arrows indicate mature oocytes. Magnification, ×100. H&E, hematoxylin and eosin; POF, premature ovarian failure; WT, wild-type; AMH, anti-Müllerian hormone; FSHR, follicle stimulating hormone receptor.](MMR-14-03-2415-g00){#f1-mmr-14-03-2415}

![Characteristics of POF mice. (A) The weight of ovarian tissues from POF mice was significantly reduced compared with control mice. (B) The peripheral blood E2 level in POF mice was significantly reduced compared with control mice. (C) The peripheral blood FSH level in POF mice was significantly increased compared with control mice. ^\*^P\<0.05 vs. WT; n=20. POF, premature ovarian failure; WT, wild-type; E2, estradiol; FSH, follicle stimulating hormone.](MMR-14-03-2415-g01){#f2-mmr-14-03-2415}

![Transmission electron microscopy of ovarian tissues. Telocyte-like cells were observed in the stroma of ovarian tissues in mice of the WT group; these cells had a triangular cell body and telopode-like prolongations with a dichotomous branching structure. However, cells with these morphological features were not observed in the ovaries of POF mice. The yellow circle indicates a telocyte-like cell in the magnification of the blue square from the WT image. Scale bar=5 *µ*m; magnification, ×5,000. POF, premature ovarian failure; WT, wild-type.](MMR-14-03-2415-g02){#f3-mmr-14-03-2415}

![Detection of the expression levels of telocyte markers in ovarian tissues by flow cytometry. The number of CD34/PDGFRα, CD34/PDGFRβ and CD34/vimentin double-positive cells in ovarian cells in WT mice was significantly increased compared with POF mice. ^\#^P\>0.05, ^\*^P\<0.05 and ^\*\*^P\<0.01 vs. WT; n=10. POF, premature ovarian failure; WT, wild-type; CD, cluster of differentiation; PDGFR, platelet-derived growth factor receptor; c-kit, CD117; FITC, fluorescein isothiocyanate; Cy3, cyanine 3.](MMR-14-03-2415-g03){#f4-mmr-14-03-2415}

![Detection of the expression of telocyte markers in ovarian tissues by immunohistochemistry. The number of CD34/PDGFRα, CD34/PDGFRβ and CD34/vimentin double-positive cells in ovarian tissues from POF mice was decreased compared with WT mice. POF, premature ovarian failure; WT, wild-type; CD, cluster of differentiation; PDGFR, platelet-derived growth factor receptor; c-kit, CD117; FITC, fluorescein isothiocyanate; Cy3, cyanine 3.](MMR-14-03-2415-g04){#f5-mmr-14-03-2415}

###### 

Primary antibodies.

  Target      Species raised in   Species raised against   Application   Dilution   Catalog no.   Supplier
  ----------- ------------------- ------------------------ ------------- ---------- ------------- ----------
  Inhibin α   Rabbit              Mouse                    IHC           1:100      sc-30146      SC
  Inhibin β   Rabbit              Mouse                    IHC           1:100      sc-50288      SC
  AMH         Rabbit              Mouse                    IHC           1:100      ab103233      AB
  FSHR        Rabbit              Mouse                    IHC           1:100      sc-13935      SC
  PDGFRα      Rabbit              Mouse                    IF, FC        1:100      sc-431        SC
  PDGFRβ      Rabbit              Mouse                    IF, FC        1:100      sc-432        SC
  CD34        Goat                Mouse                    IF            1:100      sc-7045       SC
  c-Kit       Rabbit              Mouse                    IF, FC        1:100      sc-5535       SC
  Vimentin    Rat                 Mouse                    IF, FC        1:100      sc-5565       SC

AMH, anti-müllerian hormone; FSHR, follicle-stimulating hormone receptor; PDGFR, platelet-derived growth factor receptor; CD, cluster of differentiation; c-Kit, CD117; IHC, immunohistochemistry; IF, immunofluorescence; FC, flow cytometry; SC, Santa Cruz Biotechnology, Inc. (Dallas, TX, USA); AB, Abcam (Cambridge, MA, USA).

###### 

Secondary antibodies.

  Species raised in   Species raised against   Conjugated to   Application   Dilution   Catalog no.   Supplier
  ------------------- ------------------------ --------------- ------------- ---------- ------------- ----------
  Donkey              Goat                     Cy3             IF, FC        1:100      ab6949        AB
  Goat                Rabbit                   FITC            IF, FC        1:100      sc-2777       SC
  Goat                Rat                      FITC            IF, FC        1:100      sc-2011       SC
  Donkey              Rabbit                   HRP             IHC           1:300      ab205722      AB

Cy3, cyanine 3; FITC, fluorescein isothiocyanate; HRP, horseradish peroxidase; IHC, immunohistochemistry; IF, immunofluorescence; FC, flow cytometry; AB, Abcam (Cambridge, MA, USA); SC, Santa Cruz Biotechnology, Inc. (Dallas, TX, USA).
